Short- & long-term complications after living donor ileal (intestinal) resection

[Clark]

https://www.amjtransplant.org/article/S1600-6135(23)00056-4/fulltext

ORIGINAL ARTICLE| VOLUME 22, ISSUE 12, P3053-3060, DECEMBER 2022Short- and long-term complications after living donor ileal resection

      Guosheng Wu

Chaoxu Liu
Xile Zhou

      Mian Wang
Qingchuan Zhao
Tingbo Liang

et al.
American Journal of Transplantation
DOI:https://doi.org/10.1111/ajt.17193

Intestinal transplantation from deceased donors is the established procedure for patients with irreversible intestinal failure. However, a living-donor intestinal transplant has not been routinely performed yet because of undefined surgical risks to the donor. In this report, we reviewed our experience with living-donor ileal resection from May 1999 to December 2021. A total of 40 living-donor ileal resections were performed for 40 intestinal transplant recipients. Clinical data were prospectively collected and analyzed for postoperative complications after ileal procurement. None of the donors experienced life-threatening complications or mortality. Six (15%) of 40 donors experienced minor operative complications. Transit intestinal graft inadequacy including weight loss, diarrhea, and vitamin B12 deficiency was common early following surgery, but was manageable and disappeared in most cases within a year. All donors had significant reductions in total plasma cholesterol and low-density lipoprotein cholesterol concentrations after donation as compared with the baseline levels. With an average follow-up of 67.8 months, bilateral kidney stones occurred in one donor and gallstones in the other. All the donors have regained their normal capacity for work. Living-donor ileal resection is associated with minimal short- and long-term morbidity and remains an attractive alternative for potential recipients when suitable deceased donors are unavailable.